Joanne E Mantell1, Neetha S Morar, Landon Myer, Gita Ramjee. 1. MSPH, HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY, USA. jem57@columbia.edu
Abstract
OBJECTIVES: We examined perceptions of the effectiveness and acceptability of a candidate microbicide among 94 South African female sex workers who had participated in a phase 3 microbicide trial for HIV prevention. METHODS: Sixteen focus groups were conducted in 2001, 12 to 15 months after participants were informed that the candidate microbicide had been determined to be ineffective in preventing HIV and other sexually transmitted infections (STIs). RESULTS: Participants clearly indicated that they understood the experimental nature of the candidate microbicide, and they recognized that they had been informed after the trial that the product was ineffective. Nevertheless, most continued to believe that the candidate microbicide helped prevent HIV and other STIs, alleviated reproductive tract pain and STI symptoms, and helped to clean the vagina. CONCLUSIONS: These findings underscore the importance of understanding women's perceptions of the efficacy of candidate microbicides and the rationale for these beliefs. These issues need to be addressed in counseling throughout microbicide trials for HIV prevention. These results also demonstrate how desperate many women at high risk of HIV infection may be for new HIV prevention technologies.
OBJECTIVES: We examined perceptions of the effectiveness and acceptability of a candidate microbicide among 94 South African female sex workers who had participated in a phase 3 microbicide trial for HIV prevention. METHODS: Sixteen focus groups were conducted in 2001, 12 to 15 months after participants were informed that the candidate microbicide had been determined to be ineffective in preventing HIV and other sexually transmitted infections (STIs). RESULTS:Participants clearly indicated that they understood the experimental nature of the candidate microbicide, and they recognized that they had been informed after the trial that the product was ineffective. Nevertheless, most continued to believe that the candidate microbicide helped prevent HIV and other STIs, alleviated reproductive tract pain and STI symptoms, and helped to clean the vagina. CONCLUSIONS: These findings underscore the importance of understanding women's perceptions of the efficacy of candidate microbicides and the rationale for these beliefs. These issues need to be addressed in counseling throughout microbicide trials for HIV prevention. These results also demonstrate how desperate many women at high risk of HIV infection may be for new HIV prevention technologies.
Authors: G Ramjee; N S Morar; M Alary; L Mukenge-Tshibaka; B Vuylsteke; V Ettiègne-Traoré; V Chandeying; S A Karim; L Van Damme Journal: AIDS Date: 2000-11-10 Impact factor: 4.177
Authors: Joanne E Mantell; Landon Myer; Alex Carballo-Diéguez; Zena Stein; Gita Ramjee; Neetha S Morar; Polly F Harrison Journal: Soc Sci Med Date: 2005-01 Impact factor: 4.634
Authors: Anne S Coletti; Patrick Heagerty; Amy R Sheon; Michael Gross; Beryl A Koblin; David S Metzger; George R Seage Journal: J Acquir Immune Defic Syndr Date: 2003-02-01 Impact factor: 3.731
Authors: Rochelle K Rosen; Jacob J van den Berg; Sara E Vargas; Natali Senocak; Julia G Shaw; Robert W Buckheit; Kelley Alison Smith; Kate Morrow Guthrie Journal: Contraception Date: 2015-08-11 Impact factor: 3.375
Authors: Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz Journal: Arch Sex Behav Date: 2014-01-23
Authors: Andrew Vallely; Shelley Lees; Charles Shagi; Stella Kasindi; Selephina Soteli; Natujwa Kavit; Lisa Vallely; Sheena McCormack; Robert Pool; Richard J Hayes Journal: BMC Med Ethics Date: 2010-06-13 Impact factor: 2.652
Authors: Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes Journal: PLoS One Date: 2010-05-14 Impact factor: 3.240
Authors: Robert L Cook; Julie S Downs; Jeanne Marrazzo; Galen E Switzer; Ozlem Tanriover; Harold Wiesenfeld; Pamela J Murray; Sharon L Hillier Journal: J Womens Health (Larchmt) Date: 2009-08 Impact factor: 2.681